Annemiek de Boer

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

W. Joost Lesterhuis, Cornelis J.A. Punt, Stanleyson V. Hato et al. · Journal of Clinical Investigation · 2011 · 347 citations · Full text

Medicine, Immunology, Oncology +17

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration

A.C.I. Boullart, Erik H.J.G. Aarntzen, Pauline Verdijk et al. · Cancer Immunology Immunotherapy · 2008 · 151 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.

W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt et al. · PubMed · 2010 · 96 citations · Full text

Medicine, Immunology, Oncology +17

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients

W. Joost Lesterhuis, I. Jolanda M. de Vries, EHJG Aarntzen et al. · British Journal of Cancer · 2010 · 64 citations · Full text

Medicine, Immunology, Oncology +15

<i>In situ</i> Expression of Tumor Antigens by Messenger RNA–Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients

Danita H. Schuurhuis, Pauline Verdijk, Gerty Schreibelt et al. · Cancer Research · 2009 · 61 citations · Full text

Life Sciences, Immunology, Oncology +17